Home

Cryoport Stock Hits Highs; More to Follow

There's a veritable gold rush going on right now in the area of personalized therapies. Companies like Novartis and Gilead (KITE) were among the...

Buying in Front of AWE

We added to one of our positions today in front of next week's Augmented World Expo (AWE) taking place in Silicon Valley. For those...

Disruption in an Unlikely Industry

Ever since humanity first began to push for innovation, there have been countless new processes and technologies which have positively enhanced entire industries. In...

MoneyOnMobile Announces Launch of New Biometric ATM Product

Tailwinds' Take: MoneyOnMobile is resuming their growth trajectory. The Company is the cheapest play on digital payments in India and is very well positioned...

CrossLayer About to Enter The Big Time

FTE Networks (FTNW) reported their earnings yesterday. The good news was that things appear to be right on track for hitting their guidance. Revenues...

Bioasis and WuXi Biologics Announce Initial Strategic Collaboration for the Development and Manufacturing of...

Tailwinds' Take: having a manufacturing partner is a key step towards clinical development of their drug candidates. With their recent financing, which we believe...

FTE Networks Reports First Quarter 2018 Results

Tailwinds' Take: This is spot on to hit their guidance, however Crosslayer is just starting to kick in which should drive upside in GM...

With Earnings Season Over, Which Stocks Surprised Us?

Quarterly earnings season is the four times each year in which companies give investors an inside look as to what's going on. They not...

Bioasis Announces Closing of First Tranche of Previously Disclosed Private Placement

Tailwinds' Take: the closing of this private placement is a key catalyst for Bioasis shares. We have been adding in the Tailwinds portfolios and...

BUYBACK TOP OR JUST NEEDLESS WORRY?

You had to know that last week’s Barron’s cover was too good for me to pass up. Come’ on. It’s just screaming at me...

MoneyOnMobile Rights Offering Subscription Period Begins

Tailwinds' Take: they have priced this basically in-line with the market and upsized the transaction, which demonstrates the demand they are seeing for offering....

ENDRA Life Sciences Reports First Quarter 2018 Financial Results

Tailwinds' Take: data now expected in July should be positive. They need financing, but, once that is accomplished, this company will be poised for...

Highlights From Catasys’ Conference Call

Yesterday, Catasys (CATS) reported Q1 results. The figures reported by CATS were very solid and should be well received by investors. For, while Q4...

Catasys Reports 2018 First Quarter Financial Results

Tailwinds' Take: great April leads to expectations that things are moving towards their guidance of $20MM in billings for 2018. Company is on the...

Fusion Reports First Quarter 2018 Financial Results

Tailwinds' Take: solid guidance, although not sure what "intermediate term" refers to. Guessing they're talking after synergies are achieved. Bottom line, very cheap stock.  NEW...

MTBC Reports First Quarter 2018 Results

Tailwinds' Take: nice to see the Y/Y increase in revenues. These guys are great at cutting costs out of businesses. If they can close...

ChromaDex Appoints Nobel Laureate, Professor Sir John Walker, to the Scientific Advisory Board

Tailwinds' Take: expect a lot more work to be done around Alzheimer's with the help of this leading researcher.  RVINE, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- ChromaDex...

Recapping This Week’s Earnings, and How Tailwinds Is Playing Each Stock

Many companies in the Tailwinds (TW) coverage universe reported earnings this last week. Here we discuss each of their results (alphabetically), along with a...

ImageWare® Systems Reports 2018 First Quarter Financial Results

Tailwinds' Take: will Q2 be the long awaited liftoff for this product? Signs seem to be pointing in that direction. SAN DIEGO, May 10, 2018...

Vuzix Provides Business Update and Reports its First Quarter 2018 Financial Results

Tailwinds' Take: still waiting for the acceleration in revenues. Remaining on the sidelines for now, but looking for the right time to get back...

Become a Tailwinds member

Because Tailwinds is in the process of becoming a Registered Investment Advisor, we are required to monitor our usage. Therefore, beginning June 1, you must be a Tailwinds Research member to read our articles. Except for Premium Membership articles related to changes in the Tailwinds Select Portfolio, all articles will always be free for viewing. However, you must register as a reader to see them going forward.

Please take the time to register for a Free or Premium membership. Thank you for your support.

SIGN ME UP